Barriers to full colon evaluation for a positive fecal occult blood test

被引:86
作者
Fisher, Deborah A.
Jeffreys, Amy
Coffman, Cynthia J.
Fasanella, Kenneth
机构
[1] Duke Univ, Med Ctr, Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA
[2] Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27705 USA
[3] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27705 USA
[4] Univ Pittsburgh, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA
关键词
D O I
10.1158/1055-9965.EPI-05-0916
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Failure to appropriately evaluate a positive cancer screening test may negate the value of doing that test. The primary aim of this study was to explore the factors associated with undergoing a full colon evaluation for a positive fecal occult blood test (FOBT) in a single Veterans Affairs center. Methods: Medical records of consecutive patients ages >= 50 years, who had a positive screening FOBT from March 2000 to February 2001, were abstracted. Patient demographics, dates of ordering and doing follow-up test(s), and adherence with scheduled procedures were collected. The primary outcome, full colon evaluation, was defined as having a colonoscopy or double-contrast barium enema plus flexible sigmoidoscopy completed within 12 months. Results: The sample (N = 538) was 98% men (58% Caucasian, 29% African-American, and 13% unknown race). Approximately 77% of the patients were referred to gastroenterology. Ultimately, only 44% underwent full colon evaluation within 12 months. Approximately 20% of the patients failed to attend a scheduled procedure. Referral to gastroenterology and adherence to follow-up appointments were associated with full colon evaluation. There was no association between African-American versus Caucasian race and full colon evaluation. Conclusions: Less than half of the patients with a positive FOBT had a full colon evaluation within 12 months. Multiple failures were identified, including lack of referral for further testing and patient nonadherence. Although the overall performance in evaluating a positive colorectal cancer screening test was poor, no racial disparity was observed.
引用
收藏
页码:1232 / 1235
页数:4
相关论文
共 20 条
[1]   Interventions to improve follow-up of abnormal findings in cancer screening [J].
Bastani, R ;
Yabroff, KR ;
Myers, RE ;
Glenn, B .
CANCER, 2004, 101 (05) :1188-1200
[2]  
Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P193
[3]  
Diggle PJ., 2002, ANAL LONGITUDINAL DA
[4]  
Dominitz JA, 1998, CANCER, V82, P2312, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2312::AID-CNCR3>3.0.CO
[5]  
2-U
[6]   Randomised controlled trial of faecal-occult-blood screening for colorectal cancer [J].
Hardcastle, JD ;
Chamberlain, JO ;
Robinson, MHE ;
Moss, SM ;
Amar, SS ;
Balfour, TW ;
James, PD ;
Mangham, CM .
LANCET, 1996, 348 (9040) :1472-1477
[7]  
Hosmer D. W., 1989, APPL LOGISTIC REGRES, DOI DOI 10.1097/00019514-200604000-00003
[8]   Fecal occult blood testing in a general medical clinic: Comparison between guaiac-based and immunochemical-based tests [J].
Ko, CW ;
Dominitz, JA ;
Nguyen, TD .
AMERICAN JOURNAL OF MEDICINE, 2003, 115 (02) :111-114
[9]   Randomised study of screening for colorectal cancer with faecal-occult-blood test [J].
Kronborg, O ;
Fenger, C ;
Olsen, J ;
Jorgensen, OD ;
Sondergaard, O .
LANCET, 1996, 348 (9040) :1467-1471
[10]   Screening for colorectal cancer - A comparison of 3 fecal occult blood tests [J].
Levin, B ;
Hess, K ;
Johnson, C .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (09) :970-976